Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Colonization and infection associated with Malassezia and Candida species in a neonatal unit.

Shattuck KE, Cochran CK, Zabransky RJ, Pasarell L, Davis JC, Malloy MH.

J Hosp Infect. 1996 Oct;34(2):123-9.

PMID:
8910754
2.

Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.

Wexler HM, Molitoris E, Murray PR, Washington J, Zabransky RJ, Edelstein PH, Finegold SM.

J Clin Microbiol. 1996 Jan;34(1):170-4. Erratum in: J Clin Microbiol 1996 Sep;34(9):2341.

3.

Pott's disease caused by Mycobacterium xenopi.

Jones PG, Schrager MA, Zabransky RJ.

Clin Infect Dis. 1995 Nov;21(5):1352. No abstract available.

PMID:
8589186
4.

Detection of vancomycin resistance in enterococci by the Alamar MIC system.

Zabransky RJ, Dinuzzo AR, Woods GL.

J Clin Microbiol. 1995 Apr;33(4):791-3.

5.

Detection of vancomycin resistance in enterococci by the Vitek AMS system.

Zabransky RJ, Di Nuzzo AR, Huber MB, Woods GL.

Diagn Microbiol Infect Dis. 1994 Oct;20(2):113-6.

PMID:
7867304
6.

Development of a standardized screening method for detection of vancomycin-resistant enterococci.

Swenson JM, Clark NC, Ferraro MJ, Sahm DF, Doern G, Pfaller MA, Reller LB, Weinstein MP, Zabransky RJ, Tenover FC.

J Clin Microbiol. 1994 Jul;32(7):1700-4.

7.

Collaborative evaluation of the Radiometer Sensititre AP80 for identification of gram-negative bacilli.

Staneck JL, Weckbach LS, Tilton RC, Zabransky RJ, Bayola-Mueller L, O'Hara CM, Miller JM.

J Clin Microbiol. 1993 May;31(5):1179-84.

8.

Review of methods for susceptibility testing of anaerobes.

Zabransky RJ.

Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1025-31. Review.

PMID:
1295756
9.

BACTEC 460 instrumentation.

Zabransky RJ.

Diagn Microbiol Infect Dis. 1992 Feb;15(2):181. No abstract available.

PMID:
1572143
10.

Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.

Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA.

J Clin Microbiol. 1990 Dec;28(12):2804-5.

11.
12.

Group C streptococcal pleurisy and pneumonia: a fulminant case and review of the literature.

Dolinski SY, Jones PG, Zabransky RJ, Rasansky M.

Infection. 1990 Jul-Aug;18(4):239-41. Review.

PMID:
2210858
13.

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.

Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN.

J Clin Microbiol. 1989 Jan;27(1):190-1.

14.
16.
17.
18.

Propionibacterium avidum as the etiologic agent of splenic abscess.

Dunne WM Jr, Kurschenbaum HA, Deshur WR, Dee TH, Samter TG, Williams JE, Zabransky RJ.

Diagn Microbiol Infect Dis. 1986 May;5(1):87-92.

PMID:
3486741
19.
20.
21.

Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.

Sutter VL, Emmerman J, Randall E, Zabransky RJ, Birk RJ.

Antimicrob Agents Chemother. 1985 Mar;27(3):424-6.

22.

Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.

Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim AT.

J Clin Microbiol. 1983 Apr;17(4):711-4.

24.

Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Sutter VL, Barry AL, Wilkins TD, Zabransky RJ.

Antimicrob Agents Chemother. 1979 Oct;16(4):495-502.

25.

Musculoskeletal infections due to Mycobacterium kansasii.

Dorff GJ, Frerichs L, Zabransky RJ, Jacobs P, Spankus JD.

Clin Orthop Relat Res. 1978 Oct;(136):244-6.

PMID:
729292
26.
27.

Comparative growth rates of selected anaerobic species in four commonly used broth media.

Sottile W 2nd, Zabransky RJ.

Antimicrob Agents Chemother. 1977 Mar;11(3):482-90.

29.

Economical agar dilution technique for susceptibility testing of anaerobes.

Hauser KJ, Johnston JA, Zabransky RJ.

Antimicrob Agents Chemother. 1975 May;7(5):712-4.

30.

Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis.

Zabransky RJ, Johnston JA, Hauser KJ.

Antimicrob Agents Chemother. 1973 Feb;3(2):152-6.

31.

Bacteroides bacteremia.

Marcoux JA, Zabransky RJ, Washington JA 2nd, Wellman WE, Martin WJ.

Minn Med. 1970 Nov;53(11):1169-76. No abstract available.

PMID:
5483898
32.

Isolation of anaerobic bacteria from clinical specimens.

Zabransky RJ.

Mayo Clin Proc. 1970 Apr;45(4):256-64. No abstract available.

PMID:
4314713
33.

Cephalexin: preliminary in vitro studies of a new orally administered cephalosporin and report of a case of endocarditis cured with cephalexin.

Zabransky RJ, Gardner MA, Geraci JE.

Mayo Clin Proc. 1969 Dec;44(12):876-85. No abstract available.

PMID:
4906646
34.
35.

Identification of Nonfermenting Gram-negative Bacilli in the Clinical Laboratory.

Zabransky RJ, Day FE.

Appl Microbiol. 1969 Feb;17(2):331-2. No abstract available.

36.

Pyocine typing of clinical strains of Pseudomonas aeruginosa.

Zabransky RJ, Day FE.

Appl Microbiol. 1969 Feb;17(2):293-6.

37.

MODIFICATIONS IN THE ASSEMBLY AND STERILIZATION OF THE KIIL DIALYZER AND QUINTON-SCRIBNER TANK.

JOHNSON WJ, ZABRANSKY RJ, MUELLER GJ, WAGONER RD, MAHER FT.

Mayo Clin Proc. 1965 Jun;40:462-72. No abstract available.

PMID:
14299793
38.

Experimental maduromycosis in the laboratory mouse.

SCHMITT JA, ZABRANSKY RJ, JANIDLO AS, PARSONS JE.

Mycopathol Mycol Appl. 1962 Nov 10;18:164-8. No abstract available.

PMID:
13992078

Supplemental Content

Loading ...
Support Center